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ABSTRACT
Cyclodipeptide synthases (CDPSs) belong to a newly
defined family of enzymes that use aminoacyl-
tRNAs (aa-tRNAs) as substrates to synthesize the
two peptide bonds of various cyclodipeptides,
which are the precursors of many natural products
with noteworthy biological activities. Here, we
describe the crystal structure of AlbC, a CDPS
from Streptomyces noursei. The AlbC structure
consists of a monomer containing a Rossmann-
fold domain. Strikingly, it is highly similar to the
catalytic domain of class-I aminoacyl-tRNA
synthetases (aaRSs), especially class-Ic TyrRSs
and TrpRSs. AlbC contains a deep pocket, highly
conserved among CDPSs. Site-directed mutagen-
esis studies indicate that this pocket accommo-
dates the aminoacyl moiety of the aa-tRNA
substrate in a way similar to that used by TyrRSs
to recognize their tyrosine substrates. These
studies also suggest that the tRNA moiety of the
aa-tRNA interacts with AlbC via at least one patch
of basic residues, which is conserved among CDPSs
but not present in class-Ic aaRSs. AlbC catalyses its
two-substrate reaction via a ping-pong mechanism
with a covalent intermediate in which L-Phe is
shown to be transferred from Phe-tRNA
Phe to an
active serine. These findings provide insight into
the molecular bases of the interactions between
CDPSs and their aa-tRNAs substrates, and the cata-
lytic mechanism used by CDPSs to achieve the non-
ribosomal synthesis of cyclodipeptides.
INTRODUCTION
Cyclodipeptide synthases (CDPSs) constitute a family of
peptide-bond forming enzymes that use aminoacyl-tRNAs
(aa-tRNAs) as substrates to form various cyclodipeptides
(1). They are associated with cyclodipeptide-tailoring
enzymes in biosynthetic pathways dedicated to the synthe-
sis of diketopiperazines (DKPs) (2,3), a large class of
natural products mainly produced by microorganisms.
The CDPS family includes at least eight identiﬁed
members found in various bacterial phyla. All members
are similar in size (239–289 residues). They display a
moderate sequence similarity, but conserved residues are
found in 13 positions.
CDPSs use previously activated amino acids in the form
of aa-tRNAs and catalyse the formation of the peptide
bonds of the DKP scaffold (1) (Figure 1). Only two
other enzymes families also use loaded tRNA as substrates
to form peptide bonds (4–7): Fem aminoacyl transferases
form cross-bridges in peptidoglycan biosynthesis (8), and
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tremity of proteins for subsequent degradation (9). Fem
aa-transferases and aa-tRNA protein transferases thus
catalyse similar chemical reactions, in which the amino
acid loaded on an aa-tRNA donor is transferred to the
N-terminal amino group of a peptide or a protein
acceptor. They both also belong to the same
structural GCN5-related N-acetyltransferase (GNAT)
protein superfamily (9–11). CDPSs differ from Fem
aa-transferases and aa-tRNA protein transferases in that
they use two aa-tRNAs to form two peptide bonds,
whereas transferases use only one aa-tRNA to form only
one peptide bond. CDPSs and transferases have also dif-
ferent structural organizations. Indeed, the crystal struc-
ture of a CDPS, namely Rv2275 of Mycobacterium
tuberculosis, was recently determined (12), revealing that
Rv2275 is a homodimer, each monomer being structurally
related to class-Ic aminoacyl-tRNA synthetases (aaRSs)
(13–16). Rv2275 uses two tyrosyl-tRNA
Tyr (Tyr-
tRNA
Tyr) as substrates to produce cyclo(L-Tyr–L-Tyr)
(cYY) (1).
Here, we solved at 1.9A ˚ resolution the crystal struc-
ture of Streptomyces noursei AlbC, a CDPS that
uses mainly phenylalanyl-tRNA
Phe (Phe-tRNA
Phe) and
leucyl-tRNA
Leu (Leu-tRNA
Leu) as substrates to synthe-
size cyclo(L-Phe–L-Leu) (cFL). The AlbC structure
consists of a monomer. It contains a Rossmann-fold
domain and shares similarity with the catalytic domain
of class-Ic aaRSs, as previously reported for Rv2275
(12). The reaction catalysed by Rv2275 was suggested
to proceed via a ping-pong kinetic mechanism with a
covalent intermediate in which L-Tyr is transferred
from Tyr-tRNA
Tyr to an active serine, but such a
transfer was not conclusively demonstrated (12). Here,
we showed that the serine residue is covalently bound
to the aminoacyl transferred during the catalytic cycle,
demonstrating that CDPSs use a mechanism involving a
covalent aminoacyl-enzyme intermediate. Moreover, we
also showed that the interaction between AlbC and its
aa-tRNA substrates is driven by the binding of the sub-
strate aminoacyl moiety in a deep pocket—similar to the
tyrosine-binding pocket of TyrRSs—and the interaction
of the tRNA moiety with at least one patch of basic
residues. This provides clues about the molecular bases
of the interactions between CDPSs and their aa-tRNAs
substrates.
MATERIALS AND METHODS
Mutagenesis and puriﬁcation of AlbC and variants
The expression plasmid encoding AlbC was constructed
from the vector pQE60 (Qiagen). The resulting plasmid
encodes the full-length AlbC (residues 1–239) with the
C-terminal addition of two residues (RS) followed by a
His6 tag (1). The desired variants of AlbC were created
via PCR mutagenesis according to the QuikChange
method (Stratagene). Thirty-two variants were con-
structed (28 variants with a single mutation, and four
variants with a double mutation). For 12 variants, the
mutations are localized in the putative catalytic pocket
(L33Y/L185D, G35A, S37A, S37C, Y178A, Y178F,
E182A, E182Q, E182D, L200N, Y202A, Y202F), and
for the remaining variants, the mutations are outside
this pocket (H31A, W54A, F59A, G79A, R87A, K90A,
R91A, K94A, R97A, R98A, R99A, R98A/R99A, R101A/
R102A, S120A, Y128A, C149A, P184A, R214A/R215A,
R220A, R231A). The C-terminal His6-tagged proteins
were produced and puriﬁed as described previously
(1,17). Protein production was followed by SDS–PAGE
analyses or western blotting according to standard proto-
cols, and His-tagged proteins were visualized using
alkaline phosphatase-conjugated anti-His antibody and
BCIP/NBT solution (Sigma).
Crystallization and structure determination
Small crystals of AlbC (801010mm
3) were grown by
vapour diffusion in sitting drops at 17C by mixing 2mlo f
protein sample at 4mg/ml with 2ml reservoir solution.
First crystalline precipitates were obtained by a reverse
screening approach (18). By screening different pHs,
crystals were obtained with reservoir containing 1.7M
Na/K phosphate at pH 6.0. A screening of different addi-
tives showed that the presence of reducing agents
improves crystals size and the addition of a large excess
of dithiothreitol (DTT) (100mM) gave the best results.
These crystals were cryocooled with different cryoprotect-
ants, but they did not diffract better than 3.5A ˚ . Larger
Figure 1. The reaction catalysed by CDPSs. CDPSs use activated amino acids, in the form of aa-tRNAs, as substrates to catalyse the formation of
cyclodipeptides, also known as DKPs.
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3) were obtained by a batch
method under silicon oil and microseeding from solutions
of crushed AlbC crystals (19). The native crystals were
cryocooled with 35% glycerol and diffracted up to 1.9A ˚
on Proxima1 (Soleil, France) and ID29 (ESRF, France)
beamlines. The crystal structure was determined with
selenomethionine-substituted AlbC by MAD (multi-
wavelength anomalous dispersion) using phase informa-
tion derived from anomalous scattering data collected at
the Se K-edge. The crystals belong to the space group I4
with a single copy of the protein in the asymmetric unit.
The positions of four selenium atoms were determined by
SHELXD (20). Experimental phases were calculated in
SHARP (21), and the tracing of an initial model in
COOT that was subsequently completed by automatic
building in ArpwARP (22) using the AlbC native data set.
The ﬁnal model was reﬁned in REFMAC5 (23) to R/
Rfree values of 0.186/0.236 at 1.9A ˚ resolution with one
TLS parameter for the protein chain. In the ﬁnal model,
residues 1–27, 217, the eight C-terminal residues
[RS(His)6] introduced during cloning, and the side chain
of residue R214 were not visible in the electron density
map, they were not included in the crystallographic
model. The MolProbity score (24) for the reﬁned model
is 1.91, in the 75th percentile of structures reﬁned at com-
parable resolution. Almost all residues (97.6%) were in
favoured regions of the Ramachandran plot, and
100.0% were in allowed regions.
In the ﬁnal electron density, remaining peaks that could
not be attributed to water were modelled with three mol-
ecules of phosphate and a molecule of cyclo-dithiothreitol
(cDTT), which were present in the crystallization solution
as a precipitant agent and an additive, respectively (see
above, cDTT comes from the oxidized fraction of the
DTT used; Supplementary Figure S1). This observation
suggests that the large quantity of DTT used during
crystal optimisation served both to maintain AlbC under
its reduced state, and to feed crystals with cDTT present in
equilibrium with reduced DTT. Figures were prepared
with PyMOL (PyMOL Molecular Graphics System,
Version 1.2r3pre, Schro ¨ dinger, LLC). The programme
Superpose (25) was used for structural alignment and
Areaimol (26) for accessible surface area measurements.
The coordinates and structure factors of S. noursei AlbC
have been deposited in the Protein Data Bank (PDB)
(accession code 3OQV).
Cyclodipeptide-synthesizing activity assays
Assays with supernatants of cultures of Escherichia coli
cells expressing the genetic constructs encoding AlbC
wild-type or an AlbC variant were analysed by LC-MS/
MS as described previously (1). The in vivo activities are
reported as percentage of the wild-type activity. Error bars
represent the standard deviation for at least two independ-
ent experiments.
Detection and identiﬁcation of the covalent
aminoacyl-enzyme intermediate
To detect the covalent aminoacyl-enzyme intermediate,
puriﬁed AlbC or relevant variants were incubated with
[
3H]Phe-tRNA
Phe, the proteins were separated by SDS–
PAGE before being transferred on a polyvinylidene
ﬂuoride (PVDF) membrane, which was analysed with a
Beta-Imager
TM 2000 from Biospace (Paris, France).
Protein concentrations were quantiﬁed by UV spectros-
copy. The tritiated substrate was obtained as follows:
a 100ml reaction mixture containing 3.2mM E. coli
tRNA
Phe (Sigma), 0.32mM Phe, 0.9mM[
3H]Phe
(Phenylalanine, L [2,3,4,5,6-
3H], Perkin-Elmer,
110Ci/mmol), 2mM ATP, 1mM DTT, 20mM MgCl2,
50mM KCl, 1mM E. coli PheRS (PheRSEc)i n5 0 m M
Hepes–KOH, pH 7.0 was incubated at 30C for 30min.
Then, AlbC or AlbC variant was added at a ﬁnal concen-
tration of 1mM. After 20s incubation, the reaction was
quenched by the addition of 5ml Laemmli loading buffer
[ﬁnal concentration, 0.1% (w/v) bromophenol blue,
2% (w/v) SDS, 10% (v/v) glycerol, 50mM Tris–HCl,
pH 6.8 and 100mM DTT] followed by heating the
samples 2min at 50C. These samples were immediately
resolved by SDS–PAGE electrophoresis followed by
blotting. Blotting of proteins onto a PVDF membrane
was achieved using a semi-dry transfer blot apparatus
(Bio-Rad). After transfer (400 mA, 30min), the
membrane was dried before radioactivity analysis with
the Beta-Imager
TM 2000. This apparatus allows an
absolute counting of the tritium b particles, with a detec-
tion threshold of 0.007 cpm/mm
2 for tritium.
To identify the residue acylated and the nature of the
acylation, the aminoacyl-enzyme intermediate was
produced by a direct assay using puriﬁed Phe-tRNA
Phe.
The aminoacylation reaction was performed as described
above. Charged Phe-tRNA
Phe was recovered by phenol/
chloroform extraction and ethanol precipitation [the
loading of tRNA
Phe with Phe was estimated to be 70%,
as previously described (1)]. Two micrograms of
Phe-tRNA
Phe were mixed with 3mg of AlbC (or variant)
in 20ml of the reaction buffer containing 50mM Hepes–
KOH pH 7.0 and 50mM KCl. After 20s of incubation, a
5ml-aliquot was removed and submitted to trypsin diges-
tion: the withdrawn aliquots were diluted up to 10mli n
50mM NH4AcO2, pH 8.0 and 1ml of trypsin (400ng/ml
porcine trypsin, Promega) was added. Digestion was per-
formed at 50C up to 10min. Sample digests were then
acidiﬁed by 1.25% triﬂuoroacetic acid (TFA) in water,
desalted and concentrated by C18 ziptip and spotted
with 4-HCCA matrix solution (10mg/ml in 49.8/49.8/
0.4: CH3CN/H2O/TFA: v/v/v) on MALDI plate. MS
and MS/MS spectra were registered using a 4800
MALDI-TOF/TOF mass spectrometer (Applied
Biosystems, Foster City, USA) in a positive reﬂectron
mode. Each MS spectrum was the result of 1000 laser
shots and calibration was applied by using trypsin autoly-
sis fragments as internal standards. MS/MS analyses were
performed under post-source decay (PSD) mode. Each
MS/MS spectrum was the result of 10000 shots. The
sequence of the trypsic fragments was identiﬁed by using
Data Explorer processing software (Version 4.9, Applied
Biosystems) to assign the potential chemical modiﬁcations
of the serine or cysteine residues.
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Crystal structure of S. noursei AlbC
We produced AlbC in E. coli, puriﬁed it to homogeneity
(1) and crystallized the puriﬁed AlbC. We solved the
crystal structure of AlbC by the multi-wavelength anom-
alous dispersion (MAD) method using selenomethionine-
labelled protein. The native structure was reﬁned to a ﬁnal
R-factor/R-free of 18.6/23.6% at a resolution of 1.9A ˚
(Table 1). The crystal structure of AlbC is a monomer
that presents a compact a/b structure (Figure 2). It is
composed of a central b-sheet with ﬁve parallel b
strands (b3–b7) surrounded by ten a helices (a2–a9)
(Figure 2A). The AlbC structure contains a Rossmann-
fold domain (27) formed by strands b3–b5, helix a2 and
the C-terminal part of helix a4. This domain is followed
by a helical region composed of three main helices (a5–a7)
that pack against the Rossmann fold. The structure ends
with two b strands (b6 and b7) that extend the Rossmann
b-sheet and two small connecting helices (a8 and a9).
AlbC residues 1–27 were not visible in the electron
density map. Crystal packing analysis showed the
presence of large cavities near the residue 28 that are com-
patible with the presence of a ﬂexible N-terminal extension
(Supplementary Figure S2). Some regions of AlbC were
visible in the electron density map, but they present higher
B-factors than the rest of the protein (Supplementary
Figure S3). These regions contain the residues 38–46 in
loop b3–a2, the residues 105–111 in loop a4–b5, the
residues 215–220 in loop a8–b7, and the C-terminal
residues 236–239.
A striking feature of the structure of AlbC is the
presence of a deep (14A ˚ long) and narrow (diameter
ranging from 4 to 7A ˚ ) surface-accessible pocket, which
is delineated by helices a6, a7, a8 and b-strands b3, b4
and b6. The buried part of the pocket in AlbC is bordered
mostly by side chains of nine hydrophobic residues: L33,
V65, L119, L185, F186 and L200 at its deepest point and
V67, M152 and I208 on the edges (Figure 2B). Four add-
itional residues contribute to deﬁne the buried part of the
pocket, G35, E182 and the main chains of Y202 and
H203. Near the residue G35, the pocket presents a small
bulge bordered by the hydrophobic residues I34, F43,
L51, C201 and V230. Residues P207 and V156, the carb-
oxylate moiety of E182 and the side chains of four polar
amino acids—S37, N40, Y178, T206—deﬁne the entrance
of the pocket (Figure 2B). Additional electron density was
attributed to a molecule of phosphate and to a molecule of
cDTT, which are located at the entrance and at the
bottom, respectively, of the pocket (Figure 2B;
‘Materials and Methods’ section). The phosphate
molecule, probably present as a H2PO

4 ion at the pH
used for crystallization (pH=6), is within hydrogen
bond distances of residues Y178 and E182, and to two
water molecules. The cDTT is surrounded by hydrophobic
residues in the most buried part of the pocket and its
oxygens are within hydrogen bond distances of phosphate
and water molecules.
Table 1. Data collection, phasing and reﬁnement statistics
Native SeMet Crystal 1 SeMet Crystal 2
Data collection
Space group I4 I4 I4
Cell dimensions
a, b, c (A ˚ ) 97.2, 97.2, 45.5 97.9, 97.9, 45.5 98.0, 98.0, 45.5
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Peak Inﬂection Remote Peak
Wavelength 0.9793 0.9792 0.9794 0.9757 0.9792
Resolution (A ˚ ) 48.6–1.90 (2.00–1.90) 69.0–2.70 (2.70–2.85) 69.0–3.00 (3.16–3.00) 69.0–3.50 (3.69–3.50) 69.0–3.00 (3.16–3.00)
Rsym or Rmerge 8.70 (61.5) 8.10 (28.6) 9.80 (36.6) 9.80 (24.2) 9.10 (40.6)
I/sI 13.0 (3.10) 13.8 (4.40) 11.1 (3.50) 11.4 (5.50) 12.9 (3.80)
Completeness (%) 99.7 (100.0) 99.3 (98.9) 99.1 (99.8) 98.5 (99.7) 99.9 (100.0)
Redundancy 7.4 (6.9) 4.0 (3.8) 3.7 (3.9) 3.4 (3.6) 5.6 (5.7)
Reﬁnement
Resolution (A ˚ ) 1.90
No. reﬂections 15963
Rwork/Rfree 18.6/23.6
No. atoms
Protein 1621
Ligand/ion 23
Water 107
B-factors (A ˚ 2)
Protein 29.3
Ligand/ion 55.8
Water 36.2
Rmsd
Bond lengths (A ˚ ) 0.006
Bond angles () 0.793
Values in parentheses are for highest resolution shell.
4478 Nucleic Acids Research, 2011,Vol.39, No. 10The three-dimensional (3D) superimposition of AlbC
and Rv2275 (PDB id: 1j1u) [root mean square deviation
(rmsd) value of 2.27A ˚ over 192 Ca] revealed that the two
enzymes superimpose well despite sequence divergence
(AlbC shares 25.9 % identity and 40.6 % similarity with
Rv2275; Figure 2C). Almost all secondary-structure
elements superimpose well, in particular the Rossmann-
fold domain and the two additional strands b6 and b7.
However, there are some major differences between the
two enzymes. First, the region 50–77 of Rv2275 is
structured (strands b1, b2 and helix a1) while the corres-
ponding region of AlbC (1–27) is not observed in the
Figure 2. Crystal structure of S. noursei AlbC and comparison with that of M. tuberculosis Rv2275. (A) Overall structure of AlbC (region 28–236) in
cartoon mode, with a helices, b-strands, and loops coloured in green, yellow and grey, respectively. AlbC secondary-structure elements are numbered
according to Rv2275 numbering (12). The Rossmann-fold domain is constituted by helix a2, the C-terminal part of helix 4 and the b-sheet (b3–b5)
that is extended by two additional strands b6 and b7. A helical region (in light green), composed of helices a5, a6 and a7, packs against the
Rossmann fold. (B) Structure of the AlbC surface-accessible pocket. Residues that delineate the AlbC pocket are shown in ball and stick represen-
tation. The most buried part of the pocket is mainly constituted of hydrophobic residues (coloured in green). The entrance of the pocket is mainly
delineated by polar residues (coloured in orange). The boundaries of the pocket, calculated using the program CAVER (58), are deﬁned by a
semi-transparent grey surface. The molecules of phosphate and cDTT modelled in the electron density are shown in orange and dark green,
respectively. (C) Superimposition of the structures of AlbC and Rv2275 in cartoon representation. AlbC and Rv2275 are coloured in green and
magenta, respectively. Both proteins superpose well. Most signiﬁcant structural differences concern N- and C-terminus regions, and also relative
positions of helices a5, a6 and a8. (D) Superimposition of the surface-accessible pockets of AlbC and Rv2275, with an orientation similar to that
shown in Figure 2C. Residues represented in ball and stick are essential for CDPS activity. AlbC and Rv2275 residues are indicated by A and R
letters, respectively. The superimposition highlights the structural deviations between loops b3–a2 and b6–a2, and residues Y202
A and Y253
R located
at the entrance of the active sites.
Nucleic Acids Research, 2011,Vol.39, No. 10 4479electron density maps. At opposite, two regions of AlbC,
the loop a6–a7 and the C-terminal helix a9 are structured
in AlbC, and the corresponding regions are not observed
for Rv2275. Second, the axes of helices a5, a6 and a8 are
tilted by some degrees, so that residues located at these
helices extremities superimpose poorly. Finally, important
deviations are observed between loops, in particular loops
b3–a2, a4–b5, b6–a8 and a8–b7.
Both enzymes possess a similar surface-accessible
pocket that contains six residues conserved in the CDPS
family. Four of these residues, G35 (AlbC numbering)
belonging to the strand b3, and Y178, E182 and
P184 belonging to the helix a7, are remarkably well
superimposed. The two other conserved residues S37
and Y202, respectively, belong to loops b3–a2 and b6–
a8 that have different conformations as mentioned
above. In particular, the side chain of Y202 adopts a con-
formation directed towards solvent in AlbC whereas it is
directed towards the active site entrance and residue S37 in
Rv2275 (Figure 2D).
Structural similarity of AlbC with the catalytic domain
of the class-I aminoacyl-tRNA synthetases
We used the Dali server (28) to compare the structure
of AlbC to protein structures in the PDB. Due to the
Rossmann-fold domain, AlbC was found to share struc-
tural similarity with more than 300 proteins with a high
Z-score (Z>4) (Supplementary Table S1). Most of these
proteins are class-I aaRSs, enzymes that catalyse the acti-
vation of amino acids and their transfer to cognate tRNAs
to form aa-tRNAs. The 120 solutions with the highest
Z-scores, from 10.7 to 7.3, were all obtained with the
closely related class-Ic TyrRSs and TrpRSs, as previously
reported for Rv2275 (12). The greatest similarity is with
the archaeal Archaeglobus fulgidus (PDB id: 2cyb) and
Methanococcus jannaschii TyrRSs (TyrRSMj) (PDB id:
1zh6, 1j1u), and with the eukaryotic Entamoeba histolytica
TrpRS (TrpRSEh) (PDB id: 3hzr) (Supplementary Table
S1). The 3D superimposition of AlbC and TyrRSMj (rmsd
value of 3.5A ˚ over 160 Ca) (Figure 3) or TrpRSEh (rmsd
value of 3.0A ˚ over 163 Ca) (Supplementary Figure S4)
revealed that AlbC superimposes well with the
N-terminal catalytic domains of the two aaRSs, despite
low-sequence similarity (AlbC shares 15.5 and 15.8%
similarity with the catalytic domains of TyrRSMj and
TrpRSEh, respectively). Note that these enzymes possess
C-terminal tRNA-binding domains whereas AlbC does
not. The catalytic domains of each of the two aaRSs are
composed of a Rossmann-fold domain and a connective-
polypeptide 1 (CP1) domain that are both found in AlbC.
The overall position of the two domains is conserved
between AlbC and the two aaRSs and is mediated by sub-
stantial conservation of residues at the interface between
the two domains. Most secondary-structure elements are
well conserved, and the central b-sheets are well
superimposed, but the helices that pack against these
sheets present slight differences in length and positioning
(Figure 3; Supplementary Figure S4). Moreover, the
pocket in AlbC and the aminoacyl binding pockets in
the two aaRSs are positioned similarly relative to the
b-sheet forming part of the Rossmann-fold domain
(29–33).
However, there are some major differences between
AlbC and the two aaRSs. The hydrophobic regions of
the CP1 domains of TyrRS or TrpRS involved in the
homodimerization of these enzymes (34,35) are not
found in AlbC. In addition, when we mimicked this asso-
ciation for two AlbC monomers by superimposing them
on the crystal structure of TyrRSMj, we did not ﬁnd any
complementary dimer interface, and we observed major
steric hindrances between helices a5, a6 and a7 of each
AlbC monomer (Supplementary Figure S5A). However,
the crystal structure of Rv2275 was obtained as a
homodimer. But, the Rv2275 residues that make up the
interface belong to other secondary-structural elements
than those involved in the homodimerization of the two
aaRSs (12). Noted that these residues are not conserved in
CDPSs (Figure 4 and Supplementary Figure S5B). All
these observations are consistent with AlbC being found
as a monomer both in solution (1) and in crystal forms.
Another major difference between CDPSs and class-I
aaRSs is that CDPSs do not have the two consensus
motifs that are conserved in class-I aaRSs and are
involved in ATP binding (36–38) (Figure 4).
The pocket of AlbC, a binding site for the aminoacyl
moiety of the substrate
Using 3D superimposition, we compared the pocket in
AlbC to the conserved amino acid-binding pockets in
TyrRSMj and TrpRSEh (29–33). For example, the AlbC
pocket was compared to that of the TyrRSMj complexed
with its tyrosine substrate (Figure 5), which forms a
tRNA-binding
domain
Catalytic
domain
CP1
domain
N-terminal
domain
Figure 3. Superimposition of the structures of AlbC and TyrRSMj in
complex with its L-tyrosine substrate (PDB id: 1j1u). The two enzymes
are shown in cartoon mode, and L-tyrosine is in ball and stick coloured
in orange. The Rossmann-fold and the CP1 domains of TyrRSMj are
coloured in dark and light blue, respectively, and the corresponding
domains of AlbC are coloured in dark and light green, respectively.
The Rossmann-fold and CP1 domains of the two proteins have similar
rmsd values (3.25A ˚ over 96 Ca and 3.26A ˚ over 53 Ca, respectively).
TyrRSMj possesses two additional regions not present in AlbC: a
C-terminal domain involved in tRNA-binding and anticodon recogni-
tion coloured in grey, and a short N-terminal region coloured in light
blue.
4480 Nucleic Acids Research, 2011,Vol.39, No. 10hydrogen bond network with the conserved residues Y32,
Y151, Q155, D158 and Q173, and interacts with the
conserved residue G34 (29–31) (PDB id: 1j1u) (Figure
5A). The two pockets are positioned similarly relative to
the Rossmann-fold. Each pocket contains some residues
that are highly conserved in the corresponding family and
that are remarkably well superimposed: the AlbC residues
G35, Y178 and E182 superimpose with the TyrRSMj
residues G34, Y151 and Q155, the rmsd values on all
atoms being 1.30, 1.29 and 1.95A ˚ , respectively (Figures
4 and 5B). These structural similarities suggest that the
pocket of AlbC could accommodate the aminoacyl
* * * *   *    *    * 
AlbC         1   MLAGLVP...APDHGMREEILG.DRSRLIRQRGEHALIGISA.GN.SYFSQKNTVMLLQWAGQRFERTDV 64   
Rv2275       50  QLGRRIPEA.TAQEGFLVRPFT.QQCQIIHTEGDHAVIGVSP.GN.SYFSRQRLRDLGLWGLTNFDRVDF 115   
YvmC-Bsub    1   .MTGMVTER.RSVH.FIAEALT.ENCREIFERRRHVLVGISP.FN.SRFSEDYIYRLIGWAKAQFKSVSV 64   
pSHaeC06     1   ...........MQN.FKVDFLT.KNCKQIYQRKKHVILGISP.FT.SKYNESYIRKIIQWANSNFDDFSI 55   
Plu0297      1   .....MLHE.NSPS.FTVQGET.SRCDQIIQKGDHALIGISP.FN.SRFSKDYVVDLIQWSSHYFRQVDI 60   
Jk0923       1   ...........................MGESKQEHLIVGVSP.FN.PRFTPEWLSSAFQWGAERFNTVDV 41  
TyrRS Yeast  13  FGLITKNLQ.EVLNPQIIKDVLEVQK.....RHLKLYWGTAP.TGRPHCGYFVPMTKLADFLKAGCEVTV 75   
TyrRS BacSt  5   AELQWRGLVNQTTDEDGLRKLLNEE.......RVTLYCGFDPTADSLHIGHLATILTMRRFQQAGHRPIA 67 
TyrRS MetJa  4   FEMIKRNTS.EIISEEELREVLKK.......DEKSAYIGFEP.SGKIHLGHYLQIKKMIDLQNAGFDIII 64   
       *         *  **  *  *** **                       *          
AlbC         65  VY.VDTHIDEML.IADGRSAQ  EAERSVKRTLKDLRRRLRRSLESVG..DHA.ERFRVRSLSELQETPE 127  
Rv2275       116 VY.TDVHVAESY.EALGDSAI  EARRKAVKNIRGVRAKITTTVNELD..PAG.ARLCVRPMSEFQSNEA 178  
YvmC-Bsub    65  LL.AGHEAANLL.EALGTPRG KAERKVRKEVSRNRRFAE.RALVAH...GG.DPKAIHTFSDFIDNKA 125  
pSHaeC06     56  LL.AGEESKNLL.ECLGYSSS KANQKVRKEIKRQIRFCEDEIIKCN...KT.ITNRIHRFSDFKNNIY 117  
Plu0297      61  LLPCEREASRLL.VASGIDNV KAIKKTHREIRRHLRNLDYVISTAT..LKS.KQIRVIQFSDFSLNHD 124  
Jk0923       42  LH.PGEISMSLL.TSTGTPLG RAKRKVRQQCNRDMRNVEHALEISG..IKL.GRGKPVLISDYLQTQS 104  
TyrRS Yeast  76  LL.ADLH.AFLDNMK........APLEVVNYRAKYYELTIKAILRSINVPIE...KLKFVVGSSYQL.TP... 131  
TyrRS BacSt  68  LV.GGAT.GLIGDPSGKKSERTLNAKETVEAWSARIKEQLGRF....LDFEADGNPAKIKNNYDWIG.PL... 130 
TyrRS MetJa  65  LL.ADLH.AYLN.QK........GELDEIRKIGDYNKKVFEAM....GLK......AKYVYGSEFQL.DK... 112 
*                    *                                 *   * **         
AlbC         128 YRAVRERTDRAFEEDAEFATACEDMVRA.VVMNRPGDGV....GISAEHLRAGLNYVLAEAPLFADSPGV 192  
Rv2275       179 YRELHADLLTRLKDDEDLRAVCQDLVRR.FLSTKVGPRQ....GATATQEQVCMDYICAEAPLFLDTPAI 243  
YvmC-Bsub    126 YQLLRQEVEHAFFEQPHFRHACLDMSRE.AIIGRARGVSLMMEEVSEDMLNLAVEYVIAELPFFIGAPDI 194  
pSHaeC06     118 YIDIYKTIVDQFNTDSNFKNSCLKMSLQ.ALQSKGKNVNTSI.EITDETLEYAAQYVLAELPFFLNANPI 185  
Plu0297      125 YQSLKTQVENAFNESESFKKSCLDMSFQ.AIKGRLKGTGQYFGQIDLQLVYKALPYIFAEIPFYLNTPRL 193  
Jk0923       105 YQCRRRSVIAEFQNNQIFQDACRAMSRA.ACQSRLRVTNVNI....EPDIETAVKYIFDELPAYTHCSDL 169  
TyrRS Yeast  132 D.YT.MDIFRLSNIVS..QNDAKRAGADVVKQ...........VANPL..LSGLIYPLMQALDEQ....F 180  
TyrRS BacSt  131 D.VI.TFLRDVGKHFS..VNYMMAKESVQSRI...........ETGIS..FTEFSYMMLQAYDFL....R 179  
TyrRS MetJa  113 D.YT.LNVYRLALKTT..LKRARRSMELIARE...........DENPK..VAEVIYPIMQVNDIH....Y 161  
* *           **    *               *                  
AlbC         193 FSVP....SSVLCYHIDTPITAFLSRRETGFRAA.....EGQAYVVVRPQELADAA.......      239  
Rv2275       244 LGVP....SSLNCYHQSLPLAEMLYARGSGLRAS.....RNQGHAIVTPDGSPAE........      289  
YvmC-Bsub    195 LEVE....ETLLAYHRPWKLGEKISNHEFSICMR.....PNQGYLIVQEMAQMLSEKRITSEG      248  
pSHaeC06     186 INTQ....ETLMAYHAPWELGTNIINDQFNLKMN.....EKQGYIILTEKGDNYVKSV.....      234  
Plu0297      194 LGVK....YSTLLYHRPWSIGKGLFNGSYPIQVA.....DKQSYGIVTQL.............      234  
Jk0923       170 FEYE....TAALGYPTEWPIGKLIESGLTSLERD.....PNSSFIVIDFEKELIDD.......      216  
TyrRS Yeast  181 L......DVDCQFGGVD..QRKIFVL..AEENLPSLGY.KKRAHLMN...P
TyrRS BacSt  180 L..YETEGCRLQIGGSD..QWGNITA..GLELIRKTKGEARAFGLTI...P
TyrRS MetJa  162 L......GVDVAVGGME..QRKIHML..ARELLP.....KKVVCIHN...PV
MVPGLAQGGKMSASDPN 234 (160aa)
LVTKADGT.KFGKTESG 237 (182aa)
LTGLDGEGKMSSSKGN 211 (95aa)
α2 β3 β4
β6 α8 β7 α9
α5 α6 α7 α7a
β5 α9 β6 η2
β2 α1 β1 α2 α3 β3
α3 β4 α4 β5 η1
β3 α4 α5 β4 η1
α6 α7 α8
Figure 4. Structure-based sequence alignment of six CDPSs and three TyrRSs from the three primary kingdoms. The secondary-structural elements
of AlbC and the TyrRSMj are indicated above and below the alignment, respectively. The Rossmann-fold and the CP1 domains of AlbC are shown
in dark and light green, respectively. The N-terminal region, the Rossmann-fold domain, and the CP1 domain of the TyrRSMj are shown in yellow,
dark and light blue, respectively. The core regions of AlbC and the TyrRSMj displaying greatest structural similarity (rmsd value of 2.36A ˚ over 116
Ca) are shown with a gray background. The residues conserved among CDPSs, and those conserved among TyrRSs are indicated by a red
background. Black stars above the AlbC sequence indicate the residues that were modiﬁed by site-directed mutagenesis in this study. The basic
residues of CDPSs, which deﬁne a patch of positively charged residues belonging to the helix a4, are indicated by an orange background. The
residues that are disordered in the crystal structure of AlbC and Rv2275 are shown in grey. The residues of TyrRSs previously shown to be involved
in tyrosine recognition are indicated in dark blue; the position of the two clusters involved in acceptor stem recognition (41) are indicated by pink
lines below the TyrRSs sequences, and the residues involved in this recognition are indicated by a pink background. Black lines below the TyrRSs
sequences indicate the class I signature motifs, HIGH and KMSKS, which are involved in ATP binding. Rv2275 residues that are involved in the
interface of the dimer are shown with a green background. Protein sequence alignments were done according to structural alignments for AlbC and
TyrRSs and were corrected manually for CDPS based on previously described alignments (1). Two CDPSs are not mentioned, namely YvmC from
Bacillus thuringiensis and YvmC from B. licheniformis, because they are very close to YvmC from B. subtilis. Abbreviations: Bsub, B. subtilis; BacSt,
Geobacillus stearothermophilus; MetJa, M. jannaschii.
Nucleic Acids Research, 2011,Vol.39, No. 10 4481moiety of an aa-tRNA substrate in the same way that
TyrRSs bind their tyrosine substrates. To test this possi-
bility, we independently substituted each residue in AlbC
suspected to interact with the aminoacyl moiety of the
substrate by alanine and, where relevant, other amino
acids. We produced the resulting variants in E. coli
and compared their in vivo synthesis of cFL, the major
cyclodipeptide produced by AlbC, to that of the
wild-type enzyme (1). The substitution of Y178 with
alanine resulted in an almost inactive variant (Y178A),
and its substitution with phenylalanine gave a poorly
active variant (Y178F), despite being produced in
amounts similar to that of the wild-type enzyme (Figure
5D). The variants E182A and E182Q were inactive, and
the variant E182D had a weak but detectable activity
although its production was strongly affected. The
variant G35A was poorly active despite being abundantly
produced (Figure 5D). Thus, the hydroxyl group of Y178
and the carboxylate group of E182 are essential for AlbC
activity, suggesting that these groups may mediate
hydrogen bonds with the main chain amino group of the
substrate, in a way similar to what is described for
TyrRSMj. The conserved residue G35 is also essential for
the accommodation of the CDPS substrate. The conserved
residues Y32 and D158 in TyrRSMj form hydrogen
bonds with the hydroxyl group of the tyrosine substrate
(Figure 5A), and superimpose with the hydrophobic
residues L33 and L185, respectively, in AlbC (Figure
5B). This is consistent with hydrophobic phenylalanyl
or leucyl moieties in the AlbC substrates. To try to
accommodate a tyrosyl-tRNA
Tyr substrate in the AlbC
pocket, we attempted to construct an L33Y/L185D
AlbC variant, but the genetic construct was not expressed
(Figure 5D).
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Figure 5. Comparison of the AlbC and TyrRSMj pockets. (A) The tyrosine-binding pocket of TyrRSMj in complex with its L-tyrosine substrate.
TyrRS residues and L-tyrosine are represented in ball and stick, and coloured in blue and orange, respectively, with oxygen and nitrogen atoms
coloured in red and dark blue, respectively. (B) Superimposition of the TyrRS residues (A) with the corresponding AlbC residues. AlbC residues are
represented in ball and stick, and coloured in green, with oxygen and nitrogen atoms coloured in red and dark blue, respectively. Residues lining the
two pockets superimpose with an rmsd value of 1.49A ˚ over 32 main chain atoms. (C) The AlbC pocket in the presence of the phenylalanyl moiety of
a Phe-tRNA
Phe substrate. The phenylalanyl moiety position is mimicked on that of the L-tyrosine in the pocket of TyrRSMj, as shown in (A) and (B),
except that the hydroxyl group has been removed. The conserved residue S37 and the residue L200, which have no corresponding residues in TyrRS,
are shown in pink, with oxygen and nitrogen atoms coloured in red and dark blue, respectively. (D and E) Site-directed mutagenesis study of AlbC.
Cyclodipeptide-synthesizing activities are shown with error bars. The corresponding western blots indicating amounts of the proteins are also shown.
(D) cFL-synthesizing activities of the wild-type AlbC (in blue) and of each of the variants in which a residue conserved among CDPSs is substituted
(in grey). (E) cFL- and cYL-synthesizing activities (in blue and yellow, respectively) of the wild-type AlbC and the variant L200N. The wild-type
AlbC synthesizes 33.5±2.5mgl
1 of cFL and 4.9±0.5mgl
1 of cYL (Supplementary Figure S6).
4482 Nucleic Acids Research, 2011,Vol.39, No. 10All these data are consistent with the pocket of AlbC
being the binding site of the aminoacyl moiety of an
aa-tRNA, but do not prove it. We therefore replaced a
residue in the AlbC pocket suspected to interact with the
aminoacyl moiety of the substrate to see if this may
modify the enzyme’s speciﬁcity. The sequence alignment
of CDPSs (Figure 4), and the speciﬁcity determined for
each characterized CDPS (1), led us to focus on Rv2275
from M. tuberculosis that mainly synthesizes cyclo(L-Tyr–
L-Tyr) (cYY) (1,3). The residue L200 located near the
bottom of the AlbC pocket (Figure 5C) corresponds to
an asparagine in Rv2275 (Figure 4). This asparagine
residue may form a hydrogen bond with the hydroxyl
group of the tyrosyl moiety of a tyrosyl-tRNA
Tyr sub-
strate. We constructed the variant L200N, and tested its
in vivo speciﬁcity: it synthesized mainly cYL instead of
cFL and thus showed some of the speciﬁcity of Rv2275
(Figure 5E, Supplementary Figure S6). This indicates that
the substitution of one residue located in the AlbC pocket
is sufﬁcient to change the nature of one of the aminoacyl
residue incorporated into the cyclodipeptides it produces.
This also demonstrates that the AlbC pocket is the
binding site of the phenylalanyl moiety of the Phe-
tRNA
Phe substrate. But, this result does not provide
data on the binding of the leucyl moiety of the other
substrate, which is required to synthesize a molecule
of cFL.
Formation of a covalent intermediate during the catalytic
cycle of AlbC
The superimposition of the pockets of AlbC and TyrRSMj
revealed signiﬁcant similarities (see above), but also
intriguing differences. The strictly conserved residue S37
of AlbC has no corresponding conserved residue in class
Ic-aaRSs (Figures 4 and 5B). The position of the
phenylalanyl moiety of a Phe-tRNA
Phe in the AlbC
pocket, as predicted by analogy with the tyrosine substrate
in the TyrRSMj pocket (Figure 5C), indicates that the Og
atom of S37 would be located in the proximity of the
carbonyl carbon of the esteriﬁed Phe-tRNA
Phe substrate.
This organization together with the catalysed reaction—
the formation of a peptide bond from aminoacyl-tRNA—
suggests that S37 may be a catalytic residue serving as a
nucleophile. This is consistent with the fact that substitu-
tion of S37 with alanine resulted in an inactive variant
(S37A), but its substitution with the nucleophilic
cysteine (S37C) did not completely abolish the enzymatic
activity (Figure 5D). So, S37 may attack the carbonyl
carbon of the esteriﬁed Phe-tRNA
Phe substrate, leading
to the covalent phenylalanylation of S37. The formation
of a covalent intermediate in which L-Tyr is transferred
from Tyr-tRNA
Tyr to an active serine (S88) was also sug-
gested for Rv2275, using radioactive labelling (12).
Moreover, the S88 residue of Rv2275 was suggested to
be activated by the conserved Y253 residue, which corres-
ponds to Y202 in AlbC (12). To verify the existence of a
covalent intermediate, we further analysed AlbC and the
ﬁve variants S37A, S37C, Y178F, E182Q and Y202F.
The enzymes were incubated in the presence
of [
3H]Phe-tRNA
Phe, and they were separated by
SDS–PAGE before being transferred on a PVDF
membrane, which was analysed with a radioimager. As
observed for Rv2275, wild-type AlbC retained a high
amount of the radiolabel, whereas the variant S37A did
not retain any radiolabel. The variant S37C presented be-
haviour similar to that of the wild-type enzyme, conﬁrm-
ing the formation of a covalent intermediate and the
probable status of S37 as the point of covalent attachment
(Figure 6). The variants Y178F and E182Q retained sig-
niﬁcant amounts of the radiolabel although much less
than the wild-type enzyme (Figure 6). This result,
combined with the substantial and complete loss of
enzyme activity for the variants Y178F and E182Q, re-
spectively (Figure 5D), argues that Y178 and E182 may
play a crucial role in the good positioning of the
aminoacyl moiety of the substrate in the active site—
essential for an efﬁcient formation of the covalent inter-
mediate—concerning the variant Y202F, it retained
11% of the enzymatic activity (Figure 5D), and
at least as much radiolabel as the wild-type enzyme
(Figure 6). As the removal of the hydroxyl group in the
variant Y202F does not prevent the formation of the
covalent intermediate, this demonstrated that Y202 is
not responsible for the S37 activation in AlbC.
In order to unambiguously identify the residue acylated
and the nature of the acylation, we performed peptide
mass ﬁngerprint (PMF) analyses on trypsin-digested
AlbC, previously incubated or not with Phe-tRNA
Phe.
AlbC without substrate incubation gave two identiﬁed
fragments containing the residue S37 (fragments [29–46]
and [27–46]) (Supplementary Figure S7A). The corres-
ponding m/z of these fragments (calculated m/z 1878.94
and 2163.09, respectively) were selected and isolated as
precursor ion for PSD MS/MS sequence characterization
(Supplementary Figure S7B and C). The same experiment
performed on AlbC incubated with Phe-tRNA
Phe gave
two additional fragments (Figure 7A). The m/z of these
two fragments were 2026.01 (observed m/z 2026.00) and
2310.16 (observed m/z 2310.17), and corresponded to the
values expected for the addition of a phenylalanyl moiety
(addition of 147.07) on fragments [29–46] and [27–46],
respectively. These fragments, sequenced unambiguously
by both b- and y-ions series, contained a phenylalanyl
moiety on S37 (Figure 7B and Supplementary Figure
S8). This demonstrated the formation of a covalent inter-
mediate, in which L-Phe is transferred from Phe-tRNA
Phe
to S37 during the catalytic cycle. Moreover, the same ex-
periment was performed on relevant AlbC variants. No
modiﬁed fragments were observed for the variant S37A
(Supplementary Figure S9). For the variants E182Q and
WT S37C E182Q S37A Y202F Y178F
Figure 6. Covalent labelling of AlbC and variants by tritiated Phe
transferred from [
3H]Phe-tRNA
Phe. Enzymes were incubated with
[
3H]Phe-tRNA
Phe, as described in ‘Materials and Methods’ section,
separated on SDS–PAGE, then transferred onto a PVDF membrane
that was analysed with a radioimager.
Nucleic Acids Research, 2011,Vol.39, No. 10 4483Y178F, phenylalanylated fragments could be signiﬁcantly
detected, but in much less amounts than those obtained
with the wild-type enzyme (Supplementary Figures S10
and S11), in agreement with radiolabelling experiments
(Figure 6). These fragments were formed with amounts
insufﬁcient for PSD-MS/MS analyses (Supplementary
Figures S10 and S11). For the variant Y202F, the
phenylalanylated fragments were observed in proportions
similar to those obtained with the wild-type enzyme, and
were unambiguously sequenced (Supplementary Figure
S12). The results conﬁrm that Y202 is not responsible
for S37 activation. For the variant S37C, the
phenylalanylation of the fragments [27–49] and [29–46]
(respectively, calculated m/z of 2040.97 and 2326.13
instead of 1894.90 and 2179.06) was detected (Supple-
mentary Figure S13A). MS/MS sequencing of both m/z
demonstrated the formation of a thioester link between
the phenylalanyl moiety and the thiol group of C37
(Supplementary Figure S13B and C). All these data
allow the proposal of a mechanism for the formation of
a covalent intermediate during the catalytic cycle of the
CDPS AlbC (see Discussion section).
Distribution and role of the residues conserved among
CDPSs but located outside the active site
Seven of the 13 residues conserved among CDPSs are
outside the active site: H31, W54, F59, G79, S120, Y128
and C149 (Figure 4 and Supplementary Figure S14). Each
of G79, S120 and C149 was substituted with alanine
without any signiﬁcant effect on the activity or production
of the corresponding variants amounts (Figure 5D).
Variants H31A, W54A and F59A expressed very substan-
tially lower activities than the wild-type enzyme, and were
produced in signiﬁcantly (H31A and F59A) or substan-
tially (W54A) smaller amounts (Figure 5D). The residues
H31, W54 and F59 are located in strand b3, helix a2 and
loop a2–b4, respectively. The residue H31 is fully buried,
and its side chain makes two hydrogen bonds with the
residues D63 and S198 that are located in neighbouring
strands. The residues W54 and F59 are highly buried and
their side chains interact with hydrophobic residues from
strand b6 (Supplementary Figure S14A and B). The sub-
stitution of each of these three residues with alanine
should lead to a signiﬁcant structural destabilization,
Figure 7. Identiﬁcation of the covalent aminoacyl-enzyme intermediate. (A) Peptide mass ﬁngerprint (PMF) analysis of trypsin-digested AlbC
pre-incubated with Phe-tRNA
Phe. Arrows indicate the formation of two additional fragments compared to PMF analysis of trypsin-digested
AlbC not incubated with Phe-tRNA
Phe (Supplementary Figure S7): one at m/z 2026.00 (continuous line frame) corresponding to phenylalanylated
fragment [29–46] at m/z 1878.94, and the other at m/z 2310.17 (dashed line frame) corresponding to phenylalanylated fragment [27–46] at m/z
2163.08. (B) PSD-MS/MS spectrum of m/z 2026.00. Both b- and y-ions series identify the amino acids sequence of the modiﬁed AlbC fragment
[29–46], and the residue 37 as the phenylalanylated residue. PSD-MS/MS spectrum of m/z 2310.17 is shown in Supplementary Figure S8.
4484 Nucleic Acids Research, 2011,Vol.39, No. 10which is consistent with our results showing that the pro-
duction of the corresponding variants is strongly affected.
The substitution of Y128 by alanine did not impair the
production of the corresponding variant, but abolished
cFL synthesis (Figure 5D). The residue Y128, which is
located at the beginning of helix a5, is fully buried and
its side chain makes two hydrogen bonds with Q123 from
helix Z1 and R132 from helix a5 (Supplementary Figure
S14A and C). The substitution of Y128 by alanine should
alter the relative positions of these helices and neighbour-
ing interactions, resulting in a loss of AlbC activity.
Recognition of the tRNA moiety of the aa-tRNA
substrates by AlbC
The electrostatic potential surface of AlbC presents a
highly biased distribution of charged residues, which
could interact with the tRNA substrate by forming salt
bridges with the phosphates of the tRNA backbone or
hydrogen bonds with the nucleotide bases. In particular,
there is a large patch of positively charged residues
covering a surface of 1040 A ˚ 2 (Figure 8A). This patch is
mostly composed of residues belonging to the helix a4,
which contains nine basic residues. These residues, R87,
K90, R91, K94, R97, R98, R99, R101 and R102, protrude
toward the solvent, and a similar pattern of basic residues
is found in all CDPSs (Figures 4 and 8B). We substituted
with alanine each of the basic residues in helix a4. All the
resulting variants were produced with yields similar to that
of the wild-type enzyme but their cFL-synthesizing
activities were diverse (Figure 8C). The variants R98A,
R99A and R98A/R99A displayed only 19, 8 and <2%
of the wild-type activity, respectively. Five other variants
(K90A, K94A, R97A, R101A and R102A) had activities
that were 53–72% of the wild-type enzyme. The activities
of the two remaining variants, R87A and R91A, were
similar to that of the wild type. These results showed
that the basic residues located in the C-terminal half of
the helix a4, especially R98 and R99, are important for
cFL production, probably because they interact with the
tRNA moiety of the substrate. A second patch of basic
residues, consisting of R214, R215 and R220 from loop
a8–b7 and R231 from loop b7–a9, is present on AlbC
(Figure 8A). We substituted these residues and showed
that the corresponding variants displayed properties
similar to the wild-type enzyme (Figure 8C), indicating
that this patch is not involved in tRNA binding. This is
consistent with the fact that this patch is not conserved
among CDPSs (Figure 4). Our results suggest that the
interaction between AlbC and its aa-tRNA is driven by
the binding of the substrate aminoacyl moiety in its deep
pocket and the interaction of the tRNA moiety with at
least one patch of basic residues on helix a4.
DISCUSSION
We report the 3D structure of AlbC, a member of the
recently identiﬁed CDPS family. AlbC presents a
compact a/b structure with a Rossmann-fold domain, as
it was also recently reported for the CDPS Rv2275 (12).
We show that, although having many structural
similarities, AlbC and Rv2275 have signiﬁcant differences
that raise intriguing questions regarding the catalytic
mechanism used by the CDPSs to synthesize
cyclodipeptides.
AlbC, and Rv2275, share a high structural similarity
with the catalytic domain of class-Ic aaRSs. aaRSs
catalyse speciﬁc esteriﬁcations of particular amino acids
to their cognate tRNAs in a two-step reaction. First,
amino acids are activated with ATP to form enzyme-
bound aminoacyl-adenylate intermediates. Second, the
aminoacyl moieties are transferred to tRNAs to form
aa-tRNA products. The structural similarities concern
only the catalytic domains of class-I aaRSs, which are re-
sponsible for the binding of amino acid and ATP sub-
strates. The amino acid-binding pockets of class-I aaRSs
superimpose well with the AlbC pocket and we show that
this pocket interacts with the aminoacyl moiety of the
aminoacyl-tRNA substrate. However, AlbC does not
possess the HIGH motif involved in ATP binding that is
conserved among all catalytic domains of class-I aa-RSs
(36–38). Also, AlbC does not have the loop connecting the
catalytic domain to the C-terminal tRNA-binding
domain, which contains the second ATP-binding motif
—KMSKS—in class-I aa-RSs. This is consistent with
the fact that CDPSs do not activate amino acids using
ATP, but use already activated amino acids in the forms
of aa-tRNAs (1). Another signiﬁcant difference is that
AlbC does not possess the C-terminal domain of aaRSs,
which is crucial for their interaction with tRNAs (39).
The AlbC speciﬁcity seems to be directed mainly at the
aminoacyl moiety, and not at the sequence of the tRNA
moiety of the substrate. Indeed, the substitution of one
residue of the aminoacyl-binding pocket of AlbC by the
corresponding residue of Rv2275 gave a variant that, in
E. coli, mainly bound tyrosyl-tRNA
Tyr rather than
phenylalanyl-tRNA
Phe. Comparing the acceptor stems of
the two tRNA moieties revealed that they share the se-
quences of the single-strand extremity (A
76C
75C
74A
73) and
the ﬁrst base pair (C
72–G
1), suggesting that some speciﬁ-
city determinants could lay in these conserved sequences
of the tRNA moiety of the substrate. We previously
showed that AlbC is able to efﬁciently use various
E. coli aa-tRNAs to synthesize various cyclodipeptides
(1). We compared the sequences of all E. coli aa-tRNAs
that can serve as substrates for AlbC (predominantly
phenylalanyl- and leucyl-tRNAs, and to a lesser extent
methionyl-, tyrosyl-, alanyl- and valyl-tRNAs). For all
these tRNA families, we found molecules that also share
the same sequence: A
76C
75C
74A
73C
72-G
1. This might
suggest that sequences of the single-strand extremity and
the ﬁrst base pair, but not those of the double-stranded
acceptor stem, are speciﬁcally recognized by AlbC. Noted
that aa-tRNA protein transferases recognize the aa-tRNA
in a tRNA sequence-independent manner, the double-
stranded acceptor stem being fully dispensable (40).
An interesting question concerns the tRNA-binding
mode of AlbC. Could it be similar to that described for
class-Ic aaRSs? Recognition of tRNAs by TyrRSs and
TrpRSs mainly involves their C-terminal tRNA-binding
domains, essential for tRNA binding (39). However,
several residues belonging to helices a7 and a9 of their
Nucleic Acids Research, 2011,Vol.39, No. 10 4485N-terminal catalytic domains interact with the acceptor
stems of tRNAs (Figure 4) (29,32,41–46). AlbC does not
possess a C-terminal tRNA-binding domain like those in
aaRSs nor any residue identical to those of the N-terminal
catalytic domain involved in the tRNA interaction (Figure
4). Otherwise, we showed that a patch of basic residues,
which is conserved among CDPSs but not present in
class-I aa-RSs, is important for AlbC activity. This
patch may interact with the phosphate backbone of the
tRNA body, as proposed for aa-tRNA-protein transfer-
ases and Fem aa-transferases (47). Comparing the
position of the basic patch in AlbC with that of the
acceptor stem-binding region in TyrRSMj revealed that
they are different (Supplementary Figure S15). All these
data might suggest that the tRNA-binding mode of AlbC
is different from that of class-I aa-RSs, but this issue
remains to be addressed.
We wondered how AlbC uses two tRNA substrates to
form cyclodipeptides. One possibility is that AlbC acts as
a homodimer, each monomer interacting with one
aa-tRNA. Although AlbC was obtained as a monomer
both in solution (1) and in crystal forms, we cannot
exclude that aa-tRNA binding induces dimerization.
Noted that class-Ic aaRSs act as functional dimers, but
they are also obtained as dimers in crystals (44). Class-Ic
aaRSs dimers are mainly formed by the association of a
hydrophobic surface involving residues of the CP1 domain
of each catalytic domain (34,35). The positions of these
residues are not conserved in AlbC. In addition, when
we mimicked this association for two AlbC monomers
by superimposing them on different crystal structures of
TyrRSs or TrpRSs, we observed major steric hindrances
between helices a5, a6 and a7 of each AlbC monomer.
Therefore, it is unlikely that AlbC dimerizes in a manner
Figure 8. Basic patch residues contributing to CDPS activity. (A) Electrostatic surface potential of AlbC, mapped on its solvent-accessible surface at
contouring levels of ±5 kTe–1. Positive charge is in blue, negative charge in red. The potential was calculated using APBS in PyMol (59) (http://
www.pymol.org/) from a derived model of AlbC where the missing side chain of residue R215 and the missing residue T217 were added. AlbC
structure is shown in grey and the side chains of all mutated basic residues are identiﬁed as sticks. (B) Electrostatic surface potential of Rv2275
generated like that of AlbC. (C) Site-directed mutagenesis study of AlbC. cFL-synthesizing activity of the wild-type AlbC (in blue) and of each of the
variants in which a basic residue is substituted (in grey) are shown with error bars. The corresponding western blots indicating amounts of the
proteins are also shown. Left, the residues belonging to the helix a4; right, other basic residues.
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merization would result in a physical separation of the two
AlbC catalytic pockets, inconsistent with the formation of
two peptide bonds. This is indeed what was observed for
Rv2275, which is found as a homodimer: the residues that
make up the interface belong to other secondary structural
elements than those involved in the dimerization of
class-Ic aaRSs, and the two Rv2275 catalytic pockets are
not at the dimer interface, but are physically separated
(12). Moreover, it is unlikely that AlbC dimerizes in a
manner similar to Rv2275 since the residues that are
involved in the Rv2275 interface are not conserved in
AlbC and other CDPSs. As it seems more probable that
AlbC is active as a monomer, we considered whether AlbC
catalyses its two-substrate reaction using a ternary
complex or a ping-pong mechanism. The size of the
AlbC pocket does not appear appropriate to accommo-
date the aminoacyl moieties of two aa-tRNA substrates
concomitantly. Thus, one aa-tRNA may bind to AlbC
and its aminoacyl moiety would be stored as a covalent
intermediate, i.e. as an aminoacyl-enzyme intermediate.
The formation of a covalent intermediate resulting from
the transfer of L-Tyr from Tyr-tRNA
Tyr to an active serine
was suggested for Rv2275, but such a transfer was not
conclusively demonstrated (12). We demonstrated that
this transfer occurs in AlbC because we showed that
the active serine residue is covalently bound to the
phenylalanyl transferred from Phe-tRNA
Phe during the
catalytic cycle. An intriguing point that remains to be
determined concerns the activation of the catalytic
serine, i.e. the deprotonation of its hydroxyl group
serving as the nucleophile. For Rv2275, it was suggested
that the catalytic serine (S88) residue is activated by a
conserved tyrosine residue (Y253). This is consistent
with the hydrogen bonding of Y253 to the side chain
hydroxyl group of S88, and the much lower (by a factor
of 200) catalytic activity of the Y253F variant (12). For
AlbC, the corresponding tyrosine residue (Y202) adopts a
different conformation in the AlbC structure, and the
Y202F variant displays only a 10-fold decrease in catalytic
activity. We also unambiguously showed that the forma-
tion of the covalent aminoacyl intermediate is not affected
by the substitution of Y202 with phenylalanine,
demonstrating that Y202 is not responsible for the activa-
tion of S37 in AlbC. As no other residue in the vicinity of
S37 can account for its activation, an attractive hypothesis
is that the serine activation results from a concerted
proton shuttling mechanism involving the two adjacent
vicinal hydroxyls of the nucleotide A
76 of the tRNA
moiety (Figure 9), as it has been proposed for the riboso-
mal peptididyl transferase (48) and the FemX aa-
transferase of Weissella viridescens (49). At this stage, we
cannot exclude some rearrangements in AlbC active site
during the different steps of the reaction. The analysis of
B-factors around AlbC active site suggests that the loop
b3–a2, which precedes the position S37, may present some
ﬂexibility. The crystal structure of AlbC complexed
with different intermediates of the reaction should
clarify this point. But, whatever how the serine activation
is performed, we demonstrated that CDPSs use a ping-
pong mechanism involving a covalent aminoacyl-enzyme
intermediate. The aminoacyl-enzyme may then react
with the aminoacyl moiety of the second aa-tRNA to
form a dipeptidyl-enzyme or dipeptidyl-tRNA intermedi-
ate, which may then undergo intramolecular cyclization
leading to the formation of the cyclodipeptide product.
In conclusion, we report the crystal structure of AlbC, a
CDPS from S. noursei. It conﬁrms that CDPSs are struc-
turally similar to the catalytic domain of class-I aaRSs.
This structural similarity has provided clues about the
Figure 9. Proposed mechanism of covalent phenylalanyl-enzyme formation for AlbC. (A) Proposed anchoring of the Phe-tRNA
Phe substrate at the
AlbC active site. The residues S37, Y178 and E182, which are essential for the covalent intermediate formation (Figures 6 and 7), are represented in
green. The residue L200, shown to interact with the phenylalanyl moiety of the substrate (Figure 5E), is also represented in green. As no residue in
the AlbC active site is likely to deprotonate the hydroxyl group of S37, the S37 activation is proposed to be achieved by a concerted proton shuttling
mechanism involving the two adjacent vicinal hydroxyls of the nucleotide A
76 of the tRNA moiety. (B) The resulting covalent phenylalanyl-enzyme.
Nucleic Acids Research, 2011,Vol.39, No. 10 4487molecular bases of the interactions between CDPSs and
their aa-tRNAs substrates. Moreover, we demonstrate
that CDPSs catalyse their two-substrate reactions via a
ping-pong mechanism involving a covalent aminoacyl-
enzyme intermediate. CDPSs provide a novel example
of the exaptation of aaRSs in processes not related to
ribosomal protein synthesis. Some atypical aaRSs and
aaRS-like proteins have already been shown to be
involved in amino acid biosynthesis, RNA modiﬁcation
(50,51), and in non-ribosomal peptide synthesis (52,53).
These proteins include enzymes having the catalytic
domain of an aaRS and lacking its tRNA-binding
domain. Thus, the archaeal Asn synthetase, a paralog of
AsnRS, does not form Asn-tRNA
Asn, but synthesizes Asn
by amidation of the b-carboxyl group of aspartate with
ammonia (54). YadB (renamed glutamyl-queuosine
tRNA
Asp synthetase), a paralog of GluRS, catalyses
glutamylation of queuosine in the wobble position of
tRNA
Asp (55,56). Amino acid:[carrier protein] ligases,
which are SerRS homologues, catalyse the ATP-
dependent activation of particular amino acids and their
transfer to the phosphopantetheine prosthetic group of
carrier proteins (57). Finally, CDPSs differ from these
other aaRS-like proteins in that they have not only
diverged from conventional aaRSs, but they have also
acquired new active site residues, converting them into
self-contained cyclodipeptide-forming enzymes, which
can use aa-tRNAs as substrates.
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